Sevgin Degirmencioglu, Selim Öğüt, Nurten Bahtiyar, Birsen Aydemir, Didem Karaçetin, Fatma Behice Cinemre, Ebru Hacıosmanoğlu Aldoğan, Mehmet Emin Güneş, Alev Kural, Muhammet Bektaş
{"title":"Exploring the interplay of selenoproteins and mir-675 in breast cancer: a focus on radiotherapy effects.","authors":"Sevgin Degirmencioglu, Selim Öğüt, Nurten Bahtiyar, Birsen Aydemir, Didem Karaçetin, Fatma Behice Cinemre, Ebru Hacıosmanoğlu Aldoğan, Mehmet Emin Güneş, Alev Kural, Muhammet Bektaş","doi":"10.1080/09553002.2025.2473962","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The present study aims to investigate the changes in the expression levels of miR-675 and some selenoproteins (Sel K, Sel W, and Sel P) in patients with breast cancer, before and after radiotherapy.</p><p><strong>Subjects and methods: </strong>This study included 35 breast cancer patients who applied to the Department of Radiation Oncology for radiotherapy and 25 healthy female controls. miR-675 expressions were analyzed by using quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Western blot was conducted to determine Sel K, Sel W, and Sel P expression levels. Biochemical parameters and complete blood count were analyzed by autoanalyzer system and automatic cell counter, respectively.</p><p><strong>Results: </strong>Plasma Sel K protein expression levels were decreased in the after-radiotherapy group compared to the control and before-radiotherapy groups, but plasma miR-675 expression levels were lower in both before and after radiotherapy groups compared to the control group.</p><p><strong>Conclusion: </strong>Our findings showed that miR-675 and Sel K expression levels changed after radiotherapy in breast cancer patients. These changes may have the potential to be biomarkers for the effectiveness of radiotherapy in breast cancer.</p>","PeriodicalId":94057,"journal":{"name":"International journal of radiation biology","volume":" ","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of radiation biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/09553002.2025.2473962","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The present study aims to investigate the changes in the expression levels of miR-675 and some selenoproteins (Sel K, Sel W, and Sel P) in patients with breast cancer, before and after radiotherapy.
Subjects and methods: This study included 35 breast cancer patients who applied to the Department of Radiation Oncology for radiotherapy and 25 healthy female controls. miR-675 expressions were analyzed by using quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Western blot was conducted to determine Sel K, Sel W, and Sel P expression levels. Biochemical parameters and complete blood count were analyzed by autoanalyzer system and automatic cell counter, respectively.
Results: Plasma Sel K protein expression levels were decreased in the after-radiotherapy group compared to the control and before-radiotherapy groups, but plasma miR-675 expression levels were lower in both before and after radiotherapy groups compared to the control group.
Conclusion: Our findings showed that miR-675 and Sel K expression levels changed after radiotherapy in breast cancer patients. These changes may have the potential to be biomarkers for the effectiveness of radiotherapy in breast cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
